Comparison
Abnormal Fetal Central Nervous System Morphology C5706143 vs 17q12 Recurrent Deletion Syndrome C6011081
Clinical comparison between Abnormal Fetal Central Nervous System Morphology and 17q12 Recurrent Deletion Syndrome for differential diagnosis and treatment planning.
Abnormal Fetal Central Nervous System Morphology C5706143
Structural abnormalities of the fetal brain or spine detected during pregnancy. These require thorough evaluation and specialized care. Management depends on the specific condition and its severity.
17q12 Recurrent Deletion Syndrome C6011081
A genetic condition from deletion on chromosome 17. Can involve developmental delays, neurological features, and potential kidney involvement. Management requires regular monitoring and supportive therapies.
6 comparison axes
Onset
Abnormal Fetal Central Nervous System Morphology C5706143
Variable
17q12 Recurrent Deletion Syndrome C6011081
0-null
Onset patterns differ
Severity
Abnormal Fetal Central Nervous System Morphology C5706143
severe
17q12 Recurrent Deletion Syndrome C6011081
moderate
Different severity levels
Chronic
Abnormal Fetal Central Nervous System Morphology C5706143
Chronic
17q12 Recurrent Deletion Syndrome C6011081
Chronic
Differing course
Communicable
Abnormal Fetal Central Nervous System Morphology C5706143
No
17q12 Recurrent Deletion Syndrome C6011081
No
Different transmission
Body System
Abnormal Fetal Central Nervous System Morphology C5706143
neurologic
17q12 Recurrent Deletion Syndrome C6011081
congenital
Same/different system
Category
Abnormal Fetal Central Nervous System Morphology C5706143
neurologic
17q12 Recurrent Deletion Syndrome C6011081
genetic
Different category
Bottom line
abnormal-fetal-central-nervous-system-morphology-C5706143 and 17q12-recurrent-deletion-syndrome-C6011081 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | Abnormal Fetal Central Nervous System Morphology C5706143 | 17q12 Recurrent Deletion Syndrome C6011081 | Discriminating power |
|---|---|---|---|
| Clinical nature | Abnormal fetal brain or spine structure on prenatal assessment | Chromosome 17q12 deletion with variable congenital features | High |
| Recognition | Usually identified during pregnancy; onset of effects is variable | Present from conception but may be recognized prenatally or later | Moderate |
| Associated systems | Primarily neurologic morphology; other causes are not implied | May involve development, neurologic features, and kidneys | Moderate |
When to favor each condition
Choose Abnormal Fetal Central Nervous System Morphology C5706143 when
Prenatal imaging shows a brain or spine structural abnormality
This names the imaging finding before a specific cause is proven
High
No genetic result is available yet
A deletion syndrome should not be inferred from morphology alone
High
Counseling focuses on the anatomic abnormality and its severity
Management depends on the specific malformation, which remains undefined here
Moderate
Choose 17q12 Recurrent Deletion Syndrome C6011081 when
Testing confirms a recurrent 17q12 deletion
The genetic diagnosis is established rather than only an imaging abnormality
High
Developmental concerns occur with possible kidney involvement
This pattern fits the supplied syndrome description better than morphology alone
Moderate
Family counseling concerns inheritance or recurrence
A defined deletion supports genetic counseling; exact recurrence is not supplied
Moderate
How key tests differ
| Test | Abnormal Fetal Central Nervous System Morphology C5706143 | 17q12 Recurrent Deletion Syndrome C6011081 | Interpretation |
|---|---|---|---|
| Prenatal ultrasound or fetal MRI | Shows the structural CNS abnormality being described | May be normal or nonspecific; CNS findings are not required by the source | Imaging identifies morphology but does not diagnose 17q12 deletion |
| Chromosomal microarray or equivalent genetic test | No specific result is implied by the finding | Detects deletion involving 17q12 when the syndrome is present | Genetic confirmation separates the syndrome from an imaging description |
| Renal assessment | Not established from the CNS finding alone | May be relevant because kidney involvement can occur | Abnormal renal findings support broader evaluation but are not definitive alone |
Prognosis comparison
Abnormal Fetal Central Nervous System Morphology C5706143
- Outcome
- Prognosis is not uniform and depends on the specific CNS abnormality
- Factors
- Malformation type, severity, associated anomalies, and confirmed cause
17q12 Recurrent Deletion Syndrome C6011081
- Outcome
- Often chronic with variable developmental and possible renal effects
- Factors
- Deletion confirmation, developmental course, neurologic features, and kidney findings
Time frame: From prenatal detection through childhood and long-term follow-up
No reliable mortality or outcome figures are supplied; clinician counseling is required
Complications comparison
| Complication | Presentation |
|---|---|
| Neurodevelopmental impact | Depends on the specific malformation and is not uniform Developmental delay or neurologic features may occur Neither outcome nor severity can be predicted from these labels alone |
| Kidney involvement | Not established by abnormal fetal CNS morphology Potential kidney involvement is described Renal monitoring should be clinician-directed when the deletion is confirmed |
| Diagnostic uncertainty | May have genetic, disruptive, or other causes Cause is a defined chromosomal deletion, with variable expression Additional findings require specialist interpretation |
Patient education highlights
- HighFinding versus diagnosis
An abnormal fetal CNS scan describes structure. It does not by itself prove 17q12 deletion syndrome.
- HighNeed for specialist review
Obstetric, fetal-medicine, genetics, and pediatric specialists should interpret results in context.
- MediumVariable course
Both can have lasting effects, but exact prognosis, complications, and treatment are not established here.